Voy­ager taps new busi­ness chief amid 'sig­nif­i­cant in­ter­est' from part­ners; On­copep­tides faces an­oth­er CEO, CFO re­set

Beth Shafer was taught to leave a place bet­ter than she found it. As Voy­ager Ther­a­peu­tics’ new chief busi­ness of­fi­cer, that’s ex­act­ly what she in­tends …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.